The Effect of Controlled Diabetes and Hyperglycemia on Implant Placement with Simultaneous Horizontal Guided Bone Regeneration: A Clinical Retrospective Analysis

Table 1

Patients’ demographics and clinical features.

	Total ()		No success ()	Success ()	value
Gender
M (, %)	19	55.9	4 (66.7)	15 (53.6)	0.672
F (, %)	15	44.1	2 (33.3)	13 (43.4)
Age ()					0.413
BMI ()					0.145
Osteopenia
No (, %)	26	76.5	5 (83.3)	21 (75.0)	0.662
Yes (, %)	8	23.5	1 (16.7)	7 (25.0)
Periodontal prophylaxis
No (, %)	14	41.2	4 (66.7)	10 (35.7)	0.162
Yes (, %)	20	58.8	2 (33.3)	18 (64.3)
BOP (bleeding on probing)
No (, %)	27	79.4	5 (83.3)	22 (78.6)	0.793
Yes (, %)	7	20.6	1 (16.7)	6 (21.4)
Glycemic level
1	14	41.2	1 (16.7)	13 (46.4)	0.405
2	8	23.5	2 (33.3)	6 (21.4)
3	12	35.3	3 (50.0)	9 (32.1)
N. implants
1	21	61.8	1 (16.7)	20 (71.4)	0.042
2	10	29.4	4 (66.7)	6 (21.4)
3	3	8.8	1 (16.7)	2 (7.1)
Infrabony defect height
0	6	17.6	5 (83.3)	1 (3.6)	<0.0005
1	7	20.6	1 (16.7)	6 (21.4)
2	16	47.1	0 (0.0)	16 (57.1)
3	5	14.7	0 (0.0)	5 (17.9)
VDH(vertical defect height) ()					0.644
DW(defect width) ()					0.708
HDD(horizontal defect depth) ()
KT(keratinized tissue) ()					0.878
VDH()					<0.0005
DW()					<0.0005
KT()					0.297
EHS week 1 (early wound healing score)
2	2	5.9	2 (33.3)	0 (0.0)	0.017
6	7	20.6	1 (16.7)	6 (21.4)
7	20	58.8	2 (33.3)	18 (64.3)
8	5	14.7	1 (16.7)	4 (14.3)
EHS week 3 (early wound healing score)
8	2	5.9	2 (33.3)	0 (0.0)	0.004
9	3	8.8	1 (16.7)	2 (7.1)
10	29	85.3	3 (50.0)	26 (92.9)
Complications
No (, %)	32	94.1	4 (66.7)	28 (100.0)	0.002
Yes (, %)	2	5.9	2 (33.3)	0 (0.0)